北欧幼年特发性关节炎长期队列研究中治疗、缓解状态及分类的变化模式
该研究基于北欧幼年特发性关节炎(JIA)前瞻性人群队列,对373例患者在基线、8年及18年随访时评估治疗、疾病活动度及ILAR分类。结果显示18年时停药患者比例(70%)显著高于8年时(59.7%),但缓解率未增加(52% vs 51%)。12%患者8年至18年间ILAR分类改变,银屑病关节炎组显著增加(P<0.001),少关节型减少(P=0.02)。
要点
- 18年随访时停药比例70%显著高于8年时59.7%,但缓解率未增加(52% vs 51%)。
- 8年至18年间12%患者ILAR分类改变,近半数因一级亲属遗传信息更新。
- 银屑病关节炎组显著增加(P<0.001),少关节型减少(P=0.02),未分化组增加24%但未显著(P=0.06)。
核心结论
- 18年随访时停药患者显著多于8年随访时,但缓解率并未增加。
- ILAR分类分布在18年研究期间持续显著变化。
研究设计与样本
- 前瞻性、纵向、人群为基础的北欧JIA队列研究,纳入1997-2000年发病的510例连续病例,其中373例完成18年随访。
- 在基线、发病后8年及18年连续收集临床数据,评估治疗、疾病活动度及ILAR分类。
主要发现
- 18年随访时70%患者停药,显著高于8年随访时的59.7%。
- 18年随访时52%患者停药 vs 51%患者用药,缓解患者数未增加。
- 8年至18年间12%患者ILAR分类改变,近半数改变因一级亲属遗传信息更新。
- 同期银屑病关节炎组数量显著增加(P<0.001),少关节型组减少(P=0.02)。
- 未分化组从8年至18年随访增加24%,但未达统计学显著(P=0.06)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore sustainability of achieved remission off medication and defined International League of Associations for Rheumatology (ILAR) categories in juvenile idiopathic arthritis (JIA) and describe the trajectory of disease course over time by comparing treatment, disease activity, and ILAR categories from baseline, 8 years, and 18 years after disease onset. METHODS: A total of 373 of the 510 included patients were initially recruited consecutive cases of JIA from the prospective, longitudinal, population-based Nordic JIA cohort with disease onset during 1997-2000 from Denmark, Norway, Sweden, and Finland in an 18-year follow-up study. Clinical data were collected consecutively at baseline, 8 years, and 18 years after disease onset and were evaluated regarding treatment, disease activity, and ILAR category. RESULTS: Significantly more patients (70%) were off medication after 18 years of follow-up compared to after 8 years (59.7%); nevertheless, the number of patients in remission had not increased (52% off medication versus 51% on medication). Twelve percent of patients changed ILAR category between 8 years and 18 years after disease onset. Almost half of the changes were due to updated information about heredity in a first-degree relative. In the same period, the psoriatic arthritis group increased significantly in number (P < 0.001), in contrast to the oligoarticular category, which decreased (P = 0.02). The undifferentiated group increased 24% from 8 to 18 years of follow-up; however, this increase was not significant (P = 0.06). CONCLUSION: In this Nordic JIA cohort study, the remission rate did not increase even though significantly more patients were off medication at the 18-year follow-up compared to at the 8-year follow-up after disease onset. The distribution of patients in the ILAR categories continued to change significantly throughout the 18-year study period.
引用
- Glerup M, Arnstad ED, Rypdal V, et al. Changing Patterns in Treatment, Remission Status, and Categories in a Long-Term Nordic Cohort Study of Juvenile Idiopathic Arthritis. Arthritis Care Res (Hoboken). 2022. PMID: 35015381. doi:10.1002/acr.24857
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。